These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 36517177)

  • 1. Progressive pulmonary fibrosis: an expert group consensus statement.
    Rajan SK; Cottin V; Dhar R; Danoff S; Flaherty KR; Brown KK; Mohan A; Renzoni E; Mohan M; Udwadia Z; Shenoy P; Currow D; Devraj A; Jankharia B; Kulshrestha R; Jones S; Ravaglia C; Quadrelli S; Iyer R; Dhooria S; Kolb M; Wells AU
    Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36517177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
    Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
    Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic and Therapeutic Developments in Progressive Pulmonary Fibrosis.
    Molina-Molina M; Buendia-Roldan I; Castillo D; Caro F; Valenzuela C; Selman M
    Arch Bronconeumol; 2022 May; 58(5):418-424. PubMed ID: 35312511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
    Strykowski R; Adegunsoye A
    Immunol Allergy Clin North Am; 2023 May; 43(2):209-228. PubMed ID: 37055085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting.
    Kilpeläinen M; Hirvonen T; Perkonoja K; Hirsjärvi S
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837481
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
    Piotrowski WJ; Martusewicz-Boros MM; Białas AJ; Barczyk A; Batko B; Błasińska K; Boros PW; Górska K; Grzanka P; Jassem E; Jastrzębski D; Kaczyńska J; Kowal-Bielecka O; Kucharz E; Kuś J; Kuźnar-Kamińska B; Kwiatkowska B; Langfort R; Lewandowska K; Mackiewicz B; Majewski S; Makowska J; Miłkowska-Dymanowska J; Puścińska E; Siemińska A; Sobiecka M; Soroka-Dąda RA; Szołkowska M; Wiatr E; Ziora D; Śliwiński P
    Adv Respir Med; 2022 Oct; 90(5):425-450. PubMed ID: 36285980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
    Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
    Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database.
    Kondoh Y; Ito T; Saito K; Bao H; Sakamoto W
    Respir Investig; 2024 Jul; 62(4):702-709. PubMed ID: 38815414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
    Collins BF; Luppi F
    Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
    Cottin V; Hirani NA; Hotchkin DL; Nambiar AM; Ogura T; Otaola M; Skowasch D; Park JS; Poonyagariyagorn HK; Wuyts W; Wells AU
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30578335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases.
    Holtze C; Flaherty K; Kreuter M; Luppi F; Moua T; Vancheri C; Scholand MB
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30578337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive pulmonary Fibrosis].
    Kleiner R; Pohle S
    Ther Umsch; 2024 Feb; 81(1):12-15. PubMed ID: 38655828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese expert consensus on multidisciplinary discussion of interstitial lung disease].
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1176-1188. PubMed ID: 37989522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
    Pugashetti JV; Adegunsoye A; Wu Z; Lee CT; Srikrishnan A; Ghodrati S; Vo V; Renzoni EA; Wells AU; Garcia CK; Chua F; Newton CA; Molyneaux PL; Oldham JM
    Am J Respir Crit Care Med; 2023 Jan; 207(1):69-76. PubMed ID: 35943866
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.
    George PM; Spagnolo P; Kreuter M; Altinisik G; Bonifazi M; Martinez FJ; Molyneaux PL; Renzoni EA; Richeldi L; Tomassetti S; Valenzuela C; Vancheri C; Varone F; Cottin V; Costabel U;
    Lancet Respir Med; 2020 Sep; 8(9):925-934. PubMed ID: 32890499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive fibrosis in interstitial lung diseases - proposed definition and management.
    Martusewicz-Boros MM; Piotrowski WJ
    Adv Respir Med; 2021; 89(5):505-510. PubMed ID: 34725808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
    Fischer A; Distler J
    Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
    Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
    BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.